Finance

Lists
RHHVF:OTCMKTS
Roche Holding AG Genussscheine
$ 434.14
+1.96%
(+8.36) 1D
10-р сарын 9, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RHHVF...
Open
$ 433.82
High
$ 434.14
Low
$ 427.10
Mkt. cap
348.30Т
Avg. vol.
4.75 мян
Volume
283.00
52-wk high
$ 490.33
52-wk low
$ 318.81
Beta
0.51
Shares outstanding
702.56 сая
No. of employees
113 мян
Open
$ 433.82
High
$ 434.14
Low
$ 427.10
Mkt. cap
348.30Т
Avg. vol.
4.75 мян
Volume
283.00
52-wk high
$ 490.33
52-wk low
$ 318.81
Beta
0.51
Shares outstanding
702.56 сая
No. of employees
113 мян
News stories
From web sources and news partners
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113 мян
Founded1896 оны 10-р сарын 1
HeadquartersБазель хот, Basel City, Швейцари
SectorPharmaceutical industry
Websiteroche.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
15.75 тэрбум
15.75 тэрбум
15.73 тэрбум
15.73 тэрбум
Cost of goods sold
4.21 тэрбум
4.21 тэрбум
3.93 тэрбум
3.93 тэрбум
Cost of revenue
4.21 тэрбум
4.21 тэрбум
3.93 тэрбум
3.93 тэрбум
Research and development expenses
3.15 тэрбум
3.15 тэрбум
2.99 тэрбум
2.99 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.59 тэрбум
3.59 тэрбум
3.22 тэрбум
3.22 тэрбум
Operating expense
6.82 тэрбум
6.82 тэрбум
6.11 тэрбум
6.11 тэрбум
Total operating expenses
11.03 тэрбум
11.03 тэрбум
10.03 тэрбум
10.03 тэрбум
Operating income
4.72 тэрбум
4.72 тэрбум
5.69 тэрбум
5.69 тэрбум
Other non operating income
-10.00 сая
-10.00 сая
-15.00 сая
-15.00 сая
EBT including unusual items
3.69 тэрбум
3.69 тэрбум
4.49 тэрбум
4.49 тэрбум
EBT excluding unusual items
4.37 тэрбум
4.37 тэрбум
5.38 тэрбум
5.38 тэрбум
Income tax expense
709.00 сая
709.00 сая
824.00 сая
824.00 сая
Effective tax rate
19.20%
19.20%
18.37%
18.37%
Other operating expenses
77.50 сая
77.50 сая
-99.00 сая
-99.00 сая
Net income
2.74 тэрбум
2.74 тэрбум
3.44 тэрбум
3.44 тэрбум
Net profit margin
17.36%
17.36%
21.85%
21.85%
Earnings per share
-
-
-
-
Interest and investment income
45.00 сая
45.00 сая
43.50 сая
43.50 сая
Interest expense
-289.50 сая
-289.50 сая
-282.00 сая
-282.00 сая
Net interest expenses
-244.50 сая
-244.50 сая
-238.50 сая
-238.50 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
5.50 тэрбум
5.50 тэрбум
6.48 тэрбум
6.48 тэрбум
Gain or loss from assets sale
-21.50 сая
-21.50 сая
-2.50 сая
-2.50 сая
AI content may include mistakes. Learn more
Google аппс